Member Info for SilverFoxd

20/50/200 mda all positive, if it can break 215 resistance then should fly.

Great well run company, great management and vision. Have been shareholder for more than a decade and I think next few years will be very good. I wouldn’t be surprised if this ends up as takeover target, not my preference mind you, will take long term growth over short term profits.

Nuvation Bio Announces Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated in the United Kingdom

https://uk.finance.yahoo.com/news/nuvation-bio-announces-marketing-authorisation-120000947.html

Ashton, thanks for detailed notes and raising shareholder frustration with lack of updates.

Morning Buzz, I can hear them singing in the streets at my departure but alas, rumours of my death have been greatly exaggerated. I’m still holding firm.

Hi Jessy

You are correct. I don’t have any other accounts.

Damers

1. Yes I joined in Feb 2026. P&D crew have been here long time, so no sure what any of that proves.

2. I have no reason to believe that Supra3 is lying. If somebody else has different recollection I'm happy to hear this.

3. 80m (WFE) own the licence and are a partner - yes GLND have a part to play, but 80M have the relationship with with Greenland regulators and I would have expected them to (1) fully understand the process prior to JV (2) lead or at least be part of the team. If your point is they aren't accountable then I'll agree to disagree.

Damers, unable to defend your position, so you turn to insults. You probably think Buzz is your mate aswell.

How is your mate by the way? the one who said GS is generating revenue, remember, you actually tried to convince everyone its up and running and news is imminent. To be honest, I don't believe you did it purposely, I think you were taken in yourself. March 2027 and still no RNS.

What makes me laugh is your so invested in attacking anyone who has an opinion you fail to see the benefits - RachT constantly warned everyone about GS/HV, rather than listen, reason, you end up doing the bidding of the pump and dump crew - but your the smart one, right.

I think the GS/HV news is deeply disappointing. If March 2027 is now the target date, and management still can’t be certain they’ll meet it, you have to question the board’s ability to execute. They continually miss deadlines and consistently fail to provide meaningful updates, all while receiving substantial share awards.

The licensing issue is another example. It was ultimately 80M’s responsibility to ensure this process was completed. The board should have understood the likely timescales and begun the process as soon as the JV was signed. They may argue this has been progressing in the background, but regular, realistic updates would have gone a long way. Instead we are left wondering if the Jameson drill will happen this year.

GLND has completed its side of the side, under difficult circumstances, I would imagine RP will be furious with 80M for not doing their part, if this is the case.

I still think the current share price offers an attractive risk/reward proposition based on the upside from Disko alone. If Jameson is also drilled, the potential upside improves further.

I voted against the entire board. In my view, they have repeatedly failed on two basic aspects of running a listed company: communicating effectively with shareholders and delivering against the timelines they set themselves.

According to chat gpt

Trend

* The longer-term uptrend remains intact, with the stock still well above its 200-day moving average.

* Short-term weakness seen earlier in June appears to have reversed, and today’s move is pushing the stock back toward the top of its recent range.

Key Resistance Levels

Level Significance

$8.00 Immediate psychological resistance

$8.20-$8.25 Major technical resistance repeatedly identified by multiple models

$9.00 Previous trading zone and breakout target

$10.00+ Major resistance area from the February/March rally

The $8.20 area is the level I would watch most closely. A decisive break above it could trigger momentum buying.

Key Support Levels

Level Significance

$7.50-$7.60 Near-term support

$7.25-$7.30 20-day moving average region

$6.60-$6.70 Strong support zone

$6.00 Major trend support

A close below $7.25 would weaken the current bullish setup.

Momentum

* RSI is roughly around neutral-to-slightly-bullish territory, suggesting the stock is not overbought despite today’s rise.

* MACD readings are generally positive or improving.

Volume

Today’s volume is healthy and the price has moved strongly from the open. In biotech names, breakouts accompanied by volume are much more reliable than low-volume moves.

What the chart is saying

The chart currently resembles a compression pattern: higher lows from below and resistance overhead near $8.20. Such setups often lead to a sharp move once resistance breaks. Community traders have also been focused on the $8 level as the next key hurdle.

Technical Rating

* Short-term: 8/10 bullish

* Medium-term: 8.5/10 bullish

* Risk: High (biotech stocks can move dramatically on clinical, regulatory, or commercial news)

My interpretation is that IBRX is at an interesting point. If it can clear $8.20, the next meaningful target becomes $9–10. If it fails there, expect consolidation between roughly $6.70 and $8.20 for a while longer. The technical setup is currently stronger than NUVB’s, but biotech news will ultimately determine whether the breakout sticks.

Touched a nerve Damers x

Damers

Signs your part of pump and dump crew. Lol

* Constantly bullish posts with no discussion of risks.

* Claims that a share is “guaranteed” to rise.

* Targets based on speculation rather than evidence.

* Attacks on anyone asking critical questions.

* Posters who seem more interested in excitement than analysis.

Seriously Ashton, do you have any evidence that Pat Tremamunno isn’t selling or was it same person who said GS was up and running and generating revenue.

I don’t put you in with Ramping Crew, you’re doing some great research but difficult to take that post seriously. Time will tell I guess and you can say I told you but for now….

Hiya Jacksdad, you’re a funny one aren’t you. Turn up out of blue with Ramping Crew and insult anyone who raises a question.

This is what ChatGPT tells you if you ask to identify tell tail signs of pump and dump crew. Potential warning signs include:

* Constantly bullish posts with no discussion of risks.

* Claims that a share is “guaranteed” to rise.

* Targets based on speculation rather than evidence.

* Attacks on anyone asking critical questions.

* Posters who seem more interested in excitement than analysis.

You appear to tick all boxes - investor, righty-o

As I've said a number of times, I think 0.8p is a fantastic entry point. The price should resolve itself - however, I get very nervous when the ramping crew go into overdrive - why is this necessary to post 30 times a day the same ramp ?

RNS Positives

(1) No third-party licences can be issued. This is positive news, although it only becomes meaningful if Disko/JM ultimately discovers something commercially worthwhile. (2) Good to see the company providing an operational update (80m). Keep them coming.

RNS Neutral

(1) Jameson funding remains on track. This is confirmation of what most investors were already expecting. It helps support the share price but is unlikely to move it materially higher on its own. (2) Disko drilling remains on track. Again, this is largely confirmation of expectations. Supportive for the share price, but not a major catalyst in itself.

RNS Negatives

(1) Further delays to HV/GS, with no committed contracts and no clear completion date. This is broadly in line with what RachT had predicted and is perhaps not a huge surprise, given that any positive developments would likely have been announced earlier to reduce dilution from the 30-day VWAP in June. Nevertheless, it is disappointing. The lack of an end date and confirmed contracts is particularly concerning. (2) JM: "The Company continues to maintain guidance for drilling to start during H2 2026, subject to receipt of final approvals." The key phrase here is "subject to approval", meaning regulatory risk still exists. Looking at the GLND share price, this risk appears to be reflected already. Ultimately, I believe approval is likely, as this is a licence to explore rather than to produce oil.

Overall

(1) Selling pressure continues. Despite many hoping it has finished, it appears ongoing, with seller(s) continuing to sell into buying demand. I do not currently see a near-term end to this. (2) HV will be able to sell its 220m shares from July (assuming they have not already done so). Whether they choose to sell is open to speculation, but it remains a possibility investors should be aware of, as such further fundraising can't be discounted (3) GS remains a significant concern given the absence of a completion date, budget, or signed contracts.

That said, I still believe this represents an exceptional entry price for new shareholders. The potential upside from Disko is significant in the event of a major discovery, alongside the opportunity presented by JM. We are all invested in this stock because it carries risk, but at current levels I believe the risk/reward ratio remains very attractive.

All IMO. GLA.

The firm sees the acquisition of Nuvalent as a positive sign for Nuvation Bio, as Nuvalent competes directly with the company in the ROS1 non-small cell lung cancer space. The firm noted that GSK attributed up to $3.5 billion, almost 25% to 33% of the deal value, to Nuvalent’s ROS1 asset. RBC sees meaningful upside potential based on the ROS1 drug, Ibtrozi, alone. Moreover, GSK management explicitly said it would consider acquiring a separate ROS1 inhibitor. RBC noted that this comment puts Nuvation Bio in the spotlight as a potential target.

https://uk.finance.yahoo.com/news/acquisition-nuvalent-means-nuvation-bio-184552044.html

Great video brilliantly executed. RP could be the next Clarkson, oil not farming lol. RP is a man who gets things done, its a shame he never had time to do both GS and GLND.

“ One of the most helpful things that anybody can learn is to give up trying to catch the last eighth—or the first. These two are the most expensive eighths in the world.

Edwin Lefèvre, Reminiscences of a Stock Operator 1923”

Some that were true hundred years ago are still true today.

IlDuce,

"The stock closed up on Friday, yet you're still fixated on the sellers." - There has been persistent selling since the second week of May. One positive day doesn't represent a change in sentiment. Whether there is one seller or multiple sellers wasn't my point; my point was that sentiment doesn't change overnight. Let's see if the upward movement continues this week before drawing conclusions.

"I said HV had the potential to be a cash cow, not that it was already up and running." - I don't dispute the potential, but at some point potential needs to become reality. RachT presented some excellent analysis, and I still have concerns about how quickly we can get there and at what cost. We'd all like the outcome presented on the 28th to materialise, but I'm not prepared to ignore the challenges and simply accept everything management says—or doesn't say.

"Grateful to a poster who constantly tries to create sellers." - I think RachT provides excellent analysis, and I value hearing different viewpoints when making investment decisions. I see little value in a board that only reflects positive sentiment. In fact, there are people on these boards who would prefer that, because it makes it easier to influence less experienced PIs for their own benefit.

"I suggest this may not be the right stock for you." - Actually, it is the right stock for me. I see significant potential, but I also see significant risks. Having weighed both, I remain invested.

We can all look forward to Disko and hope for positive outcome.

Thanks RachT for the clarification on the HV £1.9m profit — very clear.

I also appreciate your response to ilDuce regarding cash burn. It seems obvious to me that if you're not generating revenue, you're spending cash. I guess ilDuce is speculating (which is perfectly fair — in the absence of news, what else do we have?) that GS is up and running and generating cash. Let's hope so. However, if I were on the 80M board, I'd be releasing an RNS to confirm that. Not only to keep shareholders informed, but also because if you have good news, wouldn't now be the ideal time to release it? The shares payable to HV are based on the 30-day VWAP in June, so a higher share price would reduce dilution. If there was ever a time to release positive news, it would be now.

As for ilDuce's point that the seller around 0.80p has finished, I'm not sure any of us can know that. We don't even know whether it was one seller or several. We've seen the price fall from 1.0p to 0.77p, so the fact it's currently stabilised around 0.80p doesn't necessarily mean the selling is over. It could simply be a pause before more stock is sold into renewed buying interest. I have no idea.

What I do know is how to read the tape, and whether it's one seller or many doesn't really matter. At the moment, I don't see a meaningful change in sentiment. Hopefully that changes soon.